Review Article
Nedaplatin: A Radiosensitizing Agent for Patients with Cervical Cancer
Table 2
Patient characteristics and treatment outcomes (Intermediate-risk patients).
| | | | RT-group | CCRT-group | -value |
| | Patient characteristics | Number of patients | | 35 | 22 | | | Age (mean) | | 49.8 | 49.6 | | | Clinical stage | IA2 | 0 | 0 | | | IB | 25 | 18 | | | IIA | 10 | 4 | | | IIB | 0 | 0 | | | Histology | Squamous cell | 27 | 13 | | | Adenocarcinoma | 5 | 0 | | | Adenosquamous | 3 | 9 | | | Others | 0 | 0 | |
| | Treatment outcome | Duration of radiotherapy | Days | 37 | 37 | NS | | Patients with recurrence (%) | | 12 (34.3) | 1 (4.5) | .01 | | PFS (months) | Mean | 29 | 36 | .0026 | | OS (months) | Mean | 32.5 | 36 | .0430 |
|
|
PFS: progression-free survival, OS: overall survival, CCRT: concurrent chemoradiotherapy, RT: radiotherapy.
|
